Biocon spinout Bicara Therapeutics snags $108 mn in Series B round
Advertisement

Biocon spinout Bicara Therapeutics snags $108 mn in Series B round

By Anuj Suvarna

  • 07 Mar 2023
Premium
Biocon spinout Bicara Therapeutics snags $108 mn in Series B round
Claire Mazumdar, CEO, Bicara Therapeutics

Bicara Therapeutics, a biotech firm floated by Kiran Mazumdar’s niece Claire Mazumdar, has secured $108 million in a Series B funding exercise. The startup had earlier raised an undisclosed capital in a seed round from Biocon, which was also its subsidiary, before spinning off in 2021.  The new round was co-led ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News